Reuters logo
BRIEF-Jazz Pharmaceuticals posts Q3 EPS of $1.03
November 7, 2017 / 9:38 PM / a month ago

BRIEF-Jazz Pharmaceuticals posts Q3 EPS of $1.03

Nov 7 (Reuters) - Jazz Pharmaceuticals Plc

* Jazz pharmaceuticals announces third quarter 2017 financial results

* Q3 adjusted earnings per share $3.22

* Q3 GAAP earnings per share $1.03

* Q3 earnings per share view $2.89 -- Thomson Reuters I/B/E/S

* Qtrly ‍total revenues $411.9 million versus $374.2 million

* Q3 revenue view $420.4 million -- Thomson Reuters I/B/E/S

* Sees ‍FY 2017 revenues $1,600 million -$1,650​ million

* Sees FY 2017 ‍gaap net income per diluted share $5.30-$6.30​

* Sees ‍FY 2017 non-GAAP adjusted net income per diluted share $10.70-$11.20​

* FY 2017 earnings per share view $10.89, revenue view $1.64 billion -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below